Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA)
K-Number: K222376 · 2022-10-03
Decision Date2022-10-03
Product CodeFMK
Advisory CommitteeSU
DecisionSubstantially Equivalent
Device Summary
Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA) is a medical device manufactured by Shandong Lianfa Medical Plastic Products Co. , Ltd.. It received FDA 510(k) clearance on 2022-10-03 under approval number K222376. The device is classified under product code FMK. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA)?
Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA) is a medical device that received FDA 510(k) clearance on 2022-10-03. It is manufactured by Shandong Lianfa Medical Plastic Products Co. , Ltd.. The 510(k) number is K222376.
When was Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA) approved by the FDA?
Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA) received FDA 510(k) clearance on 2022-10-03, under approval number K222376.
What company makes Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA)?
Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA) is manufactured by Shandong Lianfa Medical Plastic Products Co. , Ltd..
What is the FDA product code for Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA)?
The FDA product code for Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA) is FMK.
Related Clinical Trials
NCT06600880
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
NOT_YET_RECRUITING
NCT06588543
Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping
RECRUITING
NCT07580651
Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring
NOT_YET_RECRUITING
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS
ACTIVE_NOT_RECRUITING
NCT07483775
Feasibility and Health-economic Evaluation of Remote Clinical Monitoring Enabling Same-day Discharge After Bariatric Surgery
NOT_YET_RECRUITING
NCT07496346
Integration of a Robotic Platform for Clinical Monitoring of Patients With Severe Acquired Brain Injury in High-Intensity Care Units
NOT_YET_RECRUITING
Related PubMed Literature
PMID: 41810241
Diverging regulatory DNA in adaptive medical AI: US agility and EU accountability in lifecycle governance.
Frontiers in medicine (2026)
PMID: 41398461
Evaluating commercial multimodal AI for diabetic eye screening and implications for an alternative regulatory pathway.
NPJ digital medicine (2025)
PMID: 41192059
Computational modeling and simulation for medical devices: a summary of the 2024 FDA/MDIC Symposium.
Progress in biomedical engineering (Bristol, England) (2026)
PMID: 40978510
Federated learning: a privacy-preserving approach to data-centric regulatory cooperation.
Frontiers in drug safety and regulation (2025)
Other Devices by Shandong Lianfa Medical Plastic Products Co. , Ltd.
Related Devices (Code: FMK)
K153670Genteel Lancing DeviceGenteel, LLC
K172712gentleheel Micro-Preemie, gentleheel Preemie, gentleheel Newborn, gentleheel ToddlerGri Medical & Electronic Technology Co., Ltd.
K193009Promisemed Heel Blood LancetPromisemed Hangzhou Meditech Co., Ltd.
K192666Promisemed Blood Lancet, VeriFine Safety Lancet, VeriFine Mini-Safety LancetPromisemed Hangzhou Meditech Co., Ltd.
K210745Heel Incision Safety LancetSteriLance Medical (Suzhou), Inc.
K223243BD Microtainer® Contact-Activated Lancets; BD Microtainer® Quikheel LancetsBecton, Dickinson and Company
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.